Tian-Ci Yang Selected Research

Neurosyphilis (General Paresis of the Insane)

1/2022	Which Is the Optimum Antigen Concentration for the Venereal Disease Research Laboratory Test of Cerebrospinal Fluid for Neurosyphilis Diagnosis: 10 or 17 μL?
5/2019	Changes of T lymphocyte subsets in patients with HIV-negative symptomatic neurosyphilis.
1/2019	Metabolite Profiles of the Cerebrospinal Fluid in Neurosyphilis Patients Determined by Untargeted Metabolomics Analysis.
1/2019	Metabolic Disorders in Patients with Central Nervous System Infections: Associations with Neurosyphilis.
1/2017	Serological Response Predicts Normalization of Cerebrospinal Fluid Abnormalities at Six Months after Treatment in HIV-Negative Neurosyphilis Patients.
1/2017	LncRNA Expression in CD4+ T Cells in Neurosyphilis Patients.
12/2016	Macrophage migration inhibitory factor as a novel cerebrospinal fluid marker for neurosyphilis among HIV-negative patients.
8/2016	A negative nontreponemal and/or specific antitreponemal IgM test does not exclude active infectious syphilis: evidence from a rabbit infectivity test: A case report.
4/2013	Laboratory findings in neurosyphilis patients with epileptic seizures alone as the initial presenting symptom.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tian-Ci Yang Research Topics

Disease

19	Syphilis 01/2021 - 11/2010
14	Infections 07/2022 - 09/2009
9	Neurosyphilis (General Paresis of the Insane) 01/2022 - 04/2013
7	Leukocytosis (Pleocytosis) 01/2018 - 01/2013
2	COVID-19 07/2022 - 01/2021
2	Wounds and Injuries (Trauma) 01/2022 - 06/2020
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2022 - 12/2016
2	Inflammation (Inflammations) 01/2019 - 01/2018
2	Neoplasms (Cancer) 06/2012 - 05/2011
1	Urinary Tract Infections (Urinary Tract Infection) 12/2021
1	HIV Infections (HIV Infection) 05/2019
1	Central Nervous System Infections (Central Nervous System Infection) 01/2019
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 09/2018
1	Blood Coagulation Disorders 09/2018
1	Dementia (Dementias) 01/2018
1	Thrombosis (Thrombus) 01/2018
1	Cerebrospinal Fluid Leak 12/2017
1	Latent Syphilis 08/2016
1	Seizures (Absence Seizure) 04/2013
1	Syphilitic aseptic meningitis 04/2013
1	Diarrhea 09/2012
1	Coronary Disease (Coronary Heart Disease) 11/2011
1	Hemorrhagic Fever with Renal Syndrome (HFRS) 05/2011
1	Bacterial Infections (Bacterial Infection) 09/2009

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2009
5	AntibodiesIBA 01/2022 - 09/2012
4	AntigensIBA 01/2022 - 09/2009
4	Messenger RNA (mRNA)IBA 06/2020 - 06/2012
4	Immunoglobulin M (IgM)IBA 09/2018 - 05/2011
3	Immunoglobulin G (IgG)IBA 09/2018 - 11/2010
3	ReaginsIBA 01/2018 - 08/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 11/2011
2	Indicators and Reagents (Reagents)IBA 07/2022 - 05/2019
2	VaccinesIBA 01/2021 - 09/2009
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2019
2	Biological ProductsIBA 09/2018 - 06/2014
2	Penicillin G Benzathine (Benzathine Benzylpenicillin)FDA Link 01/2018 - 08/2016
2	InflammasomesIBA 01/2018 - 01/2018
2	Small Interfering RNA (siRNA)IBA 06/2012 - 05/2011
2	Gold Colloid (Colloidal Gold)IBA 05/2011 - 11/2010
2	Recombinant ProteinsIBA 05/2011 - 11/2010
1	Nucleic AcidsIBA 07/2022
1	FibrinIBA 01/2022
1	VDRL antigenIBA 01/2022
1	Ampicillin (Omnipen)FDA LinkGeneric 12/2021
1	Glutamine (L-Glutamine)FDA Link 12/2021
1	Fibronectins (Fibronectin)IBA 11/2020
1	IntegrinsIBA 11/2020
1	Matrix Metalloproteinases (MMPs)IBA 10/2019
1	Tissue Inhibitor of MetalloproteinasesIBA 10/2019
1	Metalloproteases (Metalloproteinases)IBA 10/2019
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2019
1	CholesterolIBA 01/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019
1	N-acetyltyrosineIBA 01/2019
1	Mannose (D-Mannose)IBA 01/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019
1	HypoxanthineIBA 01/2019
1	Apolipoproteins B (ApoB)IBA 01/2019
1	LactonesIBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Immunoglobulin A (IgA)IBA 09/2018
1	AutoantibodiesIBA 09/2018
1	Thromboplastin (Tissue Factor)IBA 09/2018
1	Fibrinogen (Factor I)FDA Link 09/2018
1	Anticardiolipin AntibodiesIBA 09/2018
1	beta 2-Glycoprotein I (Apolipoprotein H)IBA 09/2018
1	Leucine (L-Leucine)FDA Link 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Cardiolipins (Cardiolipin)IBA 01/2018
1	NucleotidesIBA 01/2018
1	CathepsinsIBA 01/2018
1	Cephalosporins (Cephalosporin Antibiotics)IBA 12/2017
1	QuinolonesIBA 12/2017
1	Long Noncoding RNAIBA 01/2017
1	Macrophage Migration-Inhibitory FactorsIBA 12/2016
1	Penicillin G (Benzylpenicillin)FDA LinkGeneric 08/2016
1	8-dehydroxythienamycin (NS 5)IBA 04/2013
1	Immunoglobulin E (IgE)IBA 09/2012
1	Endothelins (Endothelin)IBA 11/2011
1	toluidine redIBA 05/2011
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2011
1	RNA (Ribonucleic Acid)IBA 05/2011
1	Combined VaccinesIBA 09/2009

Therapy/Procedure

3	Therapeutics 01/2018 - 05/2011
1	Artificial Respiration (Mechanical Ventilation) 12/2017
1	Catheters 12/2017
1	Aftercare (After-Treatment) 01/2017
1	Transplantation 06/2012
1	Stents 11/2011